Skip to main content
SpringerLink
Log in

Behandlung des rubeotischen Sekundärglaukoms

  • Chapter
Retinale Gefäßerkrankungen

  • 1497 Accesses

Zusammenfassung

Das rubeotische Sekundärglaukom bei retinaler Ischämie kann in 3 Formen bzw.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alkawas AA, Shahien EA, Hussein AM (2010) Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. J Glaucoma 19: 622–626

    Article  PubMed  Google Scholar 

  • Bartz-Schmidt KU, Thumann G, Psichias A, Krieglstein GK, Heimann H (1999) Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 237:969–975

    Article  PubMed  CAS  Google Scholar 

  • Browning DJ, Scott AQ, Peterson CB, Warnock J, Zhang Z (1998) The risk of missing angle neovascularisation by omitting screening gonioscopy in acute retinal vein occlusion. Ophthalmology 105:776–784

    Article  PubMed  CAS  Google Scholar 

  • Chalam KV, Gandham S, Gupta S, Tripathi BJ, Tripathi RC (2002) Pars plana modified Baerveldt implant versus Neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmic Surg Lasers 33:383–393.

    PubMed  Google Scholar 

  • Chen TC, Ahn Yuen SJ, Sangalang MA, Fernando RE, Leuenberger EU (2002) Retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes. J Glaucoma 11:209–213

    Article  PubMed  Google Scholar 

  • Chen CH, Lai IC, Wu PC, Chen YH, Lee JJ, Liu YC, Kuo HK (2010) Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma. J Ocul Pharmacol Ther 26: 111–118

    Article  PubMed  CAS  Google Scholar 

  • Choi JY, Choi J, Kim YD (2010) Subconjunctival bevacizumab as an adjunct to trabeculectomy in eyes with refractory glaucoma: a case series. Korean J Ophthalmol 24: 47–52

    Article  PubMed  Google Scholar 

  • Faghihi H, Hajizadeh F, Mohammadi SF, Kadkhoda A, Peyman GA, Riazi-Esfahani M (2007) Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging 38:292–300

    PubMed  Google Scholar 

  • Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU and the Tuebingen Bevacizumab Study Group. Intracameral Bevacizumab for iris ruebosis. Am J Ophthalmol 2006; 142: 158–160

    Article  PubMed  CAS  Google Scholar 

  • Joussen AM, Walter P, Jonescu-Cypers CP, Koizumi K, Poulaki V, Bartz-Schmidt KU, Krieglstein GK, Kirchhof B (2003) Retinectomy for treatment of intractable glaucoma: long term results. Br J Ophthalmol 87:1094–1103

    Article  PubMed  CAS  Google Scholar 

  • Leszczynski R, Domanski R, Forminska-Kapuscik M, Mrukwa-Kominek E, Rokita-Wala I (2009) Contact transscleral cyclophotocoagulation in the treatment of neovascular glaucoma: a five-year follow-up. Med Sci Monit 15: BR84–87

    PubMed  Google Scholar 

  • Mandal AK, Majji AB, Mandal SP, Das T, Jalali S, Gothwal VK, Jain SS, Nutheti R (2002) Mitomycin-C augmented trabeculectomy for neovascular glaucoma. A preliminary report. Indian J Ophthalmol 50:287–293

    PubMed  Google Scholar 

  • Marey HM, Ellakwa AF (2011) Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma. Clin Ophthalmol 5: 841–845

    PubMed  CAS  Google Scholar 

  • Martin KR, Broadway DC (2001) Cyclodiode laser therapy for painful, blind glaucomatous eyes. Br J Ophthalmol 85:474–476

    Article  PubMed  CAS  Google Scholar 

  • Mermoud A, Salmon JF, Alexander P, Straker C, Murray AD (1993) Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology 100: 897–902

    PubMed  CAS  Google Scholar 

  • Schlote T, Bartz-Schmidt KU (2007) Treatment of rubeotic secondary glaucoma. In: Joussen AM, Gardner TW, Kirchhof B, Ryan SJ (Hrsg) Retinal Vascular Disease. Springer Berlin Heidelberg, p 274–282

    Chapter  Google Scholar 

  • Schlote T, Derse M, Rassmann K, Nicaeus T, Dietz K, Thiel H-J (2001) Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma 10: 294–301

    Article  PubMed  CAS  Google Scholar 

  • Schlote T, Ziemssen F, Bartz-Schmidt KU (2006) Pars-plana-modified Ahmed Glaucoma Valve for treatment of refractory glaucoma: a pilot study. Graefes Arch Clin Exp Ophthalmol 244: 336–341

    Article  PubMed  Google Scholar 

  • Seitz B, Gruterich M, Cursiefen C, Kruse FE (2005) Konservative und chirurgische Behandlung der neurotrophen Keratopathie. Ophthalmologe 102:15–26

    Article  PubMed  CAS  Google Scholar 

  • Sivagnavel V, Ortiz-Hurtado A, Williamson TH (2005) Diode laser transscleral cyclophotocoagulation in the management of glaucoma in patients with long-term intravitreal silicone oil. Eye 19:253–257

    Article  Google Scholar 

  • Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y (2008) Intravitreal bevacizumab to treat iris neovascularisation and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115: 1571–1580

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tagesklinik Ambimed, Klingentalstraße 9, 4057, Basel, Schweiz

    Prof. Dr. T. Schlote

  2. Klinikdirektor des Departments für Augenheilkunde, Eberhard Karls Universität Tübingen, Schleichstraße 12–16, 72076, Tübingen

    Univ.-Prof. Dr. K. U. Bartz-Schmidt

Authors
  1. Prof. Dr. T. Schlote
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Univ.-Prof. Dr. K. U. Bartz-Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schlote, T., Bartz-Schmidt, K.U. (2012). Behandlung des rubeotischen Sekundärglaukoms. In: Retinale Gefäßerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18021-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18021-7_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-18020-0

  • Online ISBN: 978-3-642-18021-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation